药代动力学
不利影响
耐受性
安慰剂
药效学
抗体
内科学
免疫球蛋白G
队列
随机对照试验
自身抗体
加药
医学
胃肠病学
免疫学
药理学
病理
替代医学
作者
Peter Kießling,Rocío Lledó‐García,Shikiko Watanabe,Grant Langdon,Diep N. H. Tran,Muhammad Bari,Louis Christodoulou,Emma Jones,Graham Price,Bryan Smith,Frank R. Brennan,Ian R. White,Stephen Jolles
标识
DOI:10.1126/scitranslmed.aan1208
摘要
= 1)]. Rozanolixizumab pharmacokinetics demonstrated nonlinear increases with dose. There were sustained dose-dependent reductions in serum IgG concentrations (IV and SC rozanolixizumab). These data provide clinical evidence for the therapeutic potential of rozanolixizumab.
科研通智能强力驱动
Strongly Powered by AbleSci AI